Organoids Market by Type and Application- Global Industry Analysis & Forecast to 2027

Published On : January 2021 Pages : 157 Category: Pharma & Healthcare Report Code : HC0115145

Organoids Market By Product Type (Stomach, Intestine, Liver, Pancreas, Lung, Brain, Kidney, and Others); Application (Developmental Biology, Disease Pathology of Infectious Disease, Regenerative Medicine, Drug Toxicity and Efficacy Testing, Drug Discovery & Personalized Medicine, and Others)- Global Industry Analysis & Forecast to 2027

Industry Outlook and Trend Analysis

The Organoids Market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period.Organoids generally requires culturing the stem cells or progenitor cells in a 3D medium. The 3D medium can be made using an extracellular matrix hydrogel such as Matrigel or Cultrex BME, which is a laminin-rich extracellular matrix. Organoids have also been created using adult stem cells extracted from the target organ, and cultured in 3D media.

Drivers and Restraints

Top-down and bottom-up approaches are used to validate the global Organoids Market and estimate the market size for company, regions segments, type segments and applications (end users). In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.

Regional Insights

The data for 2021 is an estimate, based on the history data and the integrated view of industry experts, manufacturers, distributors and end users etc.

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • India
    • Southeast Asia
    • Rest of Asia-Pacific
  • SouthAmerica
    • Brazil
    • Argentina
    • Columbia
    • Rest of South America
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Egypt
    • Nigeria
    • South Africa
    • Turkey
    • Rest of MEA

Competitive Analysis                         

The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.

  • STEMCELL Technologies, Inc.
  • Cellesce Ltd.
  • Hubrecht Organoid Technology
  • Definigen
  • 3Dnamics, Inc.
  • Organoid Therapeutics
  • PeproTech, Inc.
  • Thermo Fisher Scientific
  • Corning Incorporated (Life Sciences)
  • Merck KGgA

Some of the key questions answered by the report are:

  • What was the market size in 2017 and forecast from 2021 to 2027?
  • What will be the industry market growth from 2017 to 2027?
  • What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
  • What are the major segments leading the market growth and why?
  • Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Market Classification

·         Organoids Market, By Product Type, Estimates and Forecast, 2017-2027 ($Million)

o    Stomach

o    Intestine

o    Liver

o    Pancreas

o    Lung

o    Brain

o    Kidney

o    Others

·         Organoids Market, ByApplication, Estimates and Forecast, 2017-2027 ($Million)

o    Developmental Biology

o    Disease Pathology of Infectious Disease

o    Regenerative Medicine

o    Drug Toxicity and Efficacy Testing

o    Drug Discovery & Personalized Medicine

o    Others

·         Organoids Market, By Key Players, Estimates and Forecast, 2017-2027 ($Million)

o    STEMCELL Technologies, Inc.

o    Cellesce Ltd.

o    Hubrecht Organoid Technology

o    Definigen

o    3Dnamics, Inc.

o    Organoid Therapeutics

o    PeproTech, Inc.

o    Thermo Fisher Scientific

o    Corning Incorporated (Life Sciences)

o    Merck KGgA

·         Organoids Market, By Region, Estimates and Forecast, 2017-2027 ($Million)

o    North America

§  North America Organoids Market, By Country

o    U.S. Organoids Market

o    Canada Organoids Market

o    Mexico Organoids Market

o    Europe

§  Europe Organoids Market, By Country

o    UK Organoids Market

o    Germany Organoids Market

o    France Organoids Market

o    Russia Organoids Market

o    Italy Organoids Market

o    Rest of Europe Organoids Market

o    Asia-Pacific

§  Asia-Pacific Organoids Market, By Country

o    China Organoids Market

o    Japan Organoids Market

o    South Korea Organoids Market

o    India Organoids Market

o    Southeast Asia Organoids Market

o    Rest of Asia-Pacific Organoids Market

o    South America

§  South America Organoids Market

o    Brazil Organoids Market

o    Argentina Organoids Market

o    Columbia Organoids Market

o    Rest of South America Organoids Market

o    Middle East and Africa

§  Middle East and Africa Organoids Market

o    Saudi Arabia Organoids Market

o    UAE Organoids Market

o    Egypt Organoids Market

o    Nigeria Organoids Market

o    South Africa Organoids Market

o    TurkeyOrganoids Market

o    Rest of MEA Organoids Market

Table of Contents:

1.       Introduction

1.1.     Report Description

2.       Executive Summary

2.1.     Key Highlights

3.       Market Overview

3.1.     Introduction

3.1.1.  Market Definition

3.1.2.  Market Segmentation

3.2.     Market Dynamics

3.2.1.  Drivers

3.2.2.  Restraints

3.2.3.  Opportunities

4.       Market Analysis by Regions

4.1.     North America (United States, Canada and Mexico)

4.1.1.  United States Market Status and Outlook (2017-2027)

4.1.2.  Canada Market Status and Outlook (2017-2027)

4.1.3.  Mexico Market Status and Outlook (2017-2027)

4.2.     Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

4.2.1.  Germany Market Status and Outlook (2017-2027)

4.2.2.  France Market Status and Outlook (2017-2027)

4.2.3.  UK Market Status and Outlook (2017-2027)

4.2.4.  Russia Market Status and Outlook (2017-2027)

4.2.5.  Italy Market Status and Outlook (2017-2027)

4.2.6.  Rest of Europe Market Status and Outlook (2017-2027)

4.3.     Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)

4.3.1.  China Market Status and Outlook (2017-2027)

4.3.2.  Japan Market Status and Outlook (2017-2027)

4.3.3.  Korea Market Status and Outlook (2017-2027)

4.3.4.  India Market Status and Outlook (2017-2027)

4.3.5.  Southeast Asia Market Status and Outlook (2017-2027)

4.3.6.  Rest of Asia-Pacific Market Status and Outlook (2017-2027)

4.4.     South America (Brazil, Argentina, Columbia and Rest of South America)

4.4.1.  Brazil Market Status and Outlook (2017-2027)

4.4.2.  Argentina Market Status and Outlook (2017-2027)

4.4.3.  Columbia Market Status and Outlook (2017-2027)

4.4.4.  Rest of South America Market Status and Outlook (2017-2027)

4.5.     Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)

4.5.1.  Saudi Arabia Market Status and Outlook (2017-2027)

4.5.2.  United Arab Emirates Market Status and Outlook (2017-2027)

4.5.3.  Egypt Market Status and Outlook (2017-2027)

4.5.4.  Nigeria Market Status and Outlook (2017-2027)

4.5.5.  South Africa Market Status and Outlook (2017-2027)

4.5.6.  Turkey Market Status and Outlook (2017-2027)

4.5.7.  Rest of Middle East and Africa Market Status and Outlook (2017-2027)

5.       Organoids Market, By Product Type

5.1.     Introduction

5.2.     Global Organoids Revenue and Market Share by Product Type (2017-2021)

5.2.1.  Global Organoids Revenue and Revenue Share by Product Type (2017-2021)

5.3.     Stomach

5.3.1.  Global Stomach Revenue and Growth Rate (2017-2021)

5.4.     Intestine

5.4.1.  Global Intestine Revenue and Growth Rate (2017-2021)

5.5.     Liver

5.5.1.  Global Liver Revenue and Growth Rate (2017-2021)

5.6.     Pancreas

5.6.1.  Global Pancreas Revenue and Growth Rate (2017-2021)

5.7.     Lung

5.7.1.  Global Lung Revenue and Growth Rate (2017-2021)

5.8.     Brain

5.8.1.  Global Brain Revenue and Growth Rate (2017-2021)

5.9.     Kidney

5.9.1.  Global Kidney Revenue and Growth Rate (2017-2021)

5.10. Others

5.10.1.      Global Others Revenue and Growth Rate (2017-2021)

6.       Organoids Market, By Applications

6.1.     Introduction

6.2.     Global Organoids Revenue and Market Share by Applications (2017-2021)

6.2.1.  Global Organoids Revenue and Revenue Share by Applications (2017-2021)

6.3.     Developmental Biology

6.3.1.  Global Developmental Biology Revenue and Growth Rate (2017-2021)

6.4.     Disease Pathology of Infectious Disease

6.4.1.  Global Disease Pathology of Infectious Disease Revenue and Growth Rate (2017-2021)

6.5.     Regenerative Medicine

6.5.1.  Global Regenerative Medicine Revenue and Growth Rate (2017-2021)

6.6.     Drug Toxicity and Efficacy Testing

6.6.1.  Global Drug Toxicity and Efficacy Testing Revenue and Growth Rate (2017-2021)

6.7.     Drug Discovery & Personalized Medicine

6.7.1.  Global Drug Discovery & Personalized Medicine Revenue and Growth Rate (2017-2021)

6.8.     Others

6.8.1.  Global Others Revenue and Growth Rate (2017-2021)

7.       Organoids Market, By Region

7.1.     Introduction

7.2.     Global Organoids Revenue and Market Share by Regions

7.2.1.  Global Organoids Revenue by Regions (2017-2021)

7.3.     North America Organoids by Countries

7.3.1.  North America Organoids Revenue and Growth Rate (2017-2021)

7.3.2.  North America Organoids Revenue (Million USD) by Countries (2017-2021)

7.3.3.  United States

7.3.3.1.  United States Organoids Revenue (Millions USD) and Growth Rate (2017-2021)

7.3.4.  Canada

7.3.4.1.  Canada Organoids Revenue (Millions USD) and Growth Rate (2017-2021)

7.3.5.  Mexico

7.3.5.1.  Mexico Organoids Revenue (Millions USD) and Growth Rate (2017-2021)

7.4.     Europe Organoids by Countries

7.4.1.  Europe Organoids Revenue and Growth Rate (2017-2021)

7.4.2.  Europe Organoids Revenue (Million USD) by Countries (2017-2021)

7.4.3.  Germany

7.4.3.1.  Germany Organoids Revenue (Millions USD) and Growth Rate (2017-2021)

7.4.4.  France

7.4.4.1.  France Organoids Revenue (Millions USD) and Growth Rate (2017-2021)

7.4.5.  UK

7.4.5.1.  UK Organoids Revenue (Millions USD) and Growth Rate (2017-2021)

7.4.6.  Russia

7.4.6.1.  Russia Organoids Revenue (Millions USD) and Growth Rate (2017-2021)

7.4.7.  Italy

7.4.7.1.  Italy Organoids Revenue (Millions USD) and Growth Rate (2017-2021)

7.4.8.  Rest of Europe

7.4.8.1.  Rest of Europe Organoids Revenue (Millions USD) and Growth Rate (2017-2021)

7.5.     Asia-Pacific Organoids by Countries

7.5.1.  Asia-Pacific Organoids Revenue and Growth Rate (2017-2021)

7.5.2.  Asia-Pacific Organoids Revenue (Million USD) by Countries (2017-2021)

7.5.3.  China

7.5.3.1.  China Organoids Revenue (Millions USD) and Growth Rate (2017-2021)

7.5.4.  Japan

7.5.4.1.  Japan Organoids Revenue (Millions USD) and Growth Rate (2017-2021)

7.5.5.  Korea

7.5.5.1.  Korea Organoids Revenue (Millions USD) and Growth Rate (2017-2021)

7.5.6.  India

7.5.6.1.  India Organoids Revenue (Millions USD) and Growth Rate (2017-2021)

7.5.7.  Southeast Asia

7.5.7.1.  Southeast Asia Organoids Revenue (Millions USD) and Growth Rate (2017-2021)

7.5.8.  Rest of Asia-Pacific

7.5.8.1.  Rest of Asia-Pacific Organoids Revenue (Millions USD) and Growth Rate (2017-2021)

7.6.     South America Organoids by Countries

7.6.1.  South America Organoids Revenue and Growth Rate (2017-2021)

7.6.2.  South America Organoids Revenue (Million USD) by Countries (2017-2021)

7.6.3.  Brazil

7.6.3.1.  Brazil Organoids Revenue (Millions USD) and Growth Rate (2017-2021)

7.6.4.  Argentina

7.6.4.1.  Argentina Organoids Revenue (Millions USD) and Growth Rate (2017-2021)

7.6.5.  Columbia

7.6.5.1.  Columbia Organoids Revenue (Millions USD) and Growth Rate (2017-2021)

7.6.6.  Rest of South America

7.6.6.1.  Rest of South America Organoids Revenue (Millions USD) and Growth Rate (2017-2021)

7.7.     Middle East and Africa Organoids by Countries

7.7.1.  Middle East and Africa Organoids Revenue and Growth Rate (2017-2021)

7.7.2.  Middle East and Africa Organoids Revenue (Million USD) by Countries (2017-2021)

7.7.3.  Saudi Arabia

7.7.3.1.  Saudi Arabia Organoids Revenue (Millions USD) and Growth Rate (2017-2021)

7.7.4.  United Arab Emirates

7.7.4.1.  United Arab Emirates Organoids Revenue (Millions USD) and Growth Rate (2017-2021)

7.7.5.  Egypt

7.7.5.1.  Egypt Organoids Revenue (Millions USD) and Growth Rate (2017-2021)

7.7.6.  Nigeria

7.7.6.1.  Nigeria Organoids Revenue (Millions USD) and Growth Rate (2017-2021)

7.7.7.  South Africa

7.7.7.1.  South Africa Organoids Revenue (Millions USD) and Growth Rate (2017-2021)

7.7.8.  Turkey

7.7.8.1.  Turkey Organoids Revenue (Millions USD) and Growth Rate (2017-2021)

7.7.9.  Rest of Middle East and Africa

7.7.9.1.  Rest of Middle East and Africa Organoids Revenue (Millions USD) and Growth Rate (2017-2021)

8.       Company Profiles

8.1.     STEMCELL Technologies, Inc.

8.1.1.  Business Overview

8.1.2.   Service Portfolio

8.1.3.  Strategic Developments

8.1.4.  Financial Overview

8.2.     Cellesce Ltd.

8.2.1.  Business Overview

8.2.2.   Service Portfolio

8.2.3.  Strategic Developments

8.2.4.  Financial Overview

8.3.     Hubrecht Organoid Technology

8.3.1.  Business Overview

8.3.2.   Service Portfolio

8.3.3.  Strategic Developments

8.3.4.  Financial Overview

8.4.     Definigen

8.4.1.  Business Overview

8.4.2.   Service Portfolio

8.4.3.  Strategic Developments

8.4.4.  Financial Overview

8.5.     3Dnamics, Inc.

8.5.1.  Business Overview

8.5.2.   Service Portfolio

8.5.3.  Strategic Developments

8.5.4.  Financial Overview

8.6.     Organoid Therapeutics

8.6.1.  Business Overview

8.6.2.   Service Portfolio

8.6.3.  Strategic Developments

8.6.4.  Financial Overview

8.7.     PeproTech, Inc.

8.7.1.  Business Overview

8.7.2.   Service Portfolio

8.7.3.  Strategic Developments

8.7.4.  Financial Overview

8.8.     Thermo Fisher Scientific

8.8.1.  Business Overview

8.8.2.   Service Portfolio

8.8.3.  Strategic Developments

8.8.4.  Financial Overview

8.9.     Corning Incorporated (Life Sciences)

8.9.1.  Business Overview

8.9.2.   Service Portfolio

8.9.3.  Strategic Developments

8.9.4.  Financial Overview

8.10. Merck KGgA

8.10.1.      Business Overview

8.10.2.       Service Portfolio

8.10.3.      Strategic Developments

8.10.4.      Financial Overview

9.       Organoids Market Forecast (2022-2027)

9.1.     Global Organoids Revenue (Millions USD) and Growth Rate (2022-2027)

9.2.     Organoids Market Forecast by Regions (2022-2027)

9.2.1.  North America Organoids Market Forecast (2022-2027)

9.2.1.1.  United States Organoids Market Forecast (2022-2027)

9.2.1.2.  Canada Organoids Market Forecast (2022-2027)

9.2.1.3.  Mexico Organoids Market Forecast (2022-2027)

9.2.2.  Europe Organoids Market Forecast (2022-2027)

9.2.2.1.  Germany Organoids Market Forecast (2022-2027)

9.2.2.2.  France Organoids Market Forecast (2022-2027)

9.2.2.3.  UK Organoids Market Forecast (2022-2027)

9.2.2.4.  Russia Organoids Market Forecast (2022-2027)

9.2.2.5.  Italy Organoids Market Forecast (2022-2027)

9.2.2.6.  Rest of Europe Organoids Market Forecast (2022-2027)

9.2.3.  Asia-Pacific Organoids Market Forecast (2022-2027)

9.2.3.1.  China Organoids Market Forecast (2022-2027)

9.2.3.2.  Japan Organoids Market Forecast (2022-2027)

9.2.3.3.  Korea Organoids Market Forecast (2022-2027)

9.2.3.4.  India Organoids Market Forecast (2022-2027)

9.2.3.5.  Southeast Asia Organoids Market Forecast (2022-2027)

9.2.3.6.  Rest of Asia-Pacific Organoids Market Forecast (2022-2027)

9.2.4.  South America Organoids Market Forecast (2022-2027)

9.2.4.1.  Brazil Organoids Market Forecast (2022-2027)

9.2.4.2.  Argentina Organoids Market Forecast (2022-2027)

9.2.4.3.  Columbia Organoids Market Forecast (2022-2027)

9.2.4.4.  Rest of South America Organoids Market Forecast (2022-2027)

9.2.5.  Middle East and Africa Organoids Market Forecast (2022-2027)

9.2.5.1.  Saudi Arabia Organoids Market Forecast (2022-2027)

9.2.5.2.  United Arab Emirates Organoids Market Forecast (2022-2027)

9.2.5.3.  Egypt Organoids Market Forecast (2022-2027)

9.2.5.4.  Nigeria Organoids Market Forecast (2022-2027)

9.2.5.5.  South Africa Organoids Market Forecast (2022-2027)

9.2.5.6.  Turkey Organoids Market Forecast (2022-2027)

9.2.5.7.  Rest of Middle East and Africa Organoids Market Forecast (2022-2027)

9.3.     Organoids Market Forecast by Product Type (2022-2027)

9.3.1.  Organoids Forecast by Product Type (2022-2027)

9.3.2.  Organoids Market Share Forecast by Product Type (2022-2027)

9.4.     Organoids Market Forecast by Applications (2022-2027)

9.4.1.  Organoids Forecast by Applications (2022-2027)

9.4.2.  Organoids Market Share Forecast by Applications (2022-2027)


List of Tables

List of Tables and Figures:

Figure United States Organoids Revenue (Million USD) and Growth Rate (2017-2027)
Figure Canada Organoids Revenue (Million USD) and Growth Rate (2017-2027)
Figure Mexico Organoids Revenue (Million USD) and Growth Rate (2017-2027)
Figure Germany Organoids Revenue (Million USD) and Growth Rate (2017-2027)
Figure France Organoids Revenue (Million USD) and Growth Rate (2017-2027)
Figure UK Organoids Revenue (Million USD) and Growth Rate (2017-2027)
Figure Russia Organoids Revenue (Million USD) and Growth Rate (2017-2027)
Figure Italy Organoids Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Europe Organoids Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Organoids Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Organoids Revenue (Million USD) and Growth Rate (2017-2027)
Figure Korea Organoids Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Organoids Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Organoids Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Asia-Pacific Organoids Revenue (Million USD) and Growth Rate (2017-2027)
Figure Brazil Organoids Revenue (Million USD) and Growth Rate (2017-2027)
Figure Argentina Organoids Revenue (Million USD) and Growth Rate (2017-2027)
Figure Columbia Organoids Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of South America Organoids Revenue (Million USD) and Growth Rate (2017-2027)
Figure Saudi Arabia Organoids Revenue (Million USD) and Growth Rate (2017-2027)
Figure United Arab Emirates Organoids Revenue (Million USD) and Growth Rate (2017-2027)
Figure Egypt Organoids Revenue (Million USD) and Growth Rate (2017-2027)
Figure Nigeria Organoids Revenue (Million USD) and Growth Rate (2017-2027)
Figure South Africa Organoids Revenue (Million USD) and Growth Rate (2017-2027)
Figure Turkey Organoids Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Middle East and Africa Organoids Revenue (Million USD) and Growth Rate (2017-2027)
Table Global Organoids Revenue and Revenue Share by Product Type (2017-2019)
Figure Global Stomach Revenue and Growth Rate (2017-2019)
Figure Global Intestine Revenue and Growth Rate (2017-2019)
Figure Global Liver Revenue and Growth Rate (2017-2019)
Figure Global Pancreas Revenue and Growth Rate (2017-2019)
Figure Global Lung Revenue and Growth Rate (2017-2019)
Figure Global Brain Revenue and Growth Rate (2017-2019)
Figure Global Kidney Revenue and Growth Rate (2017-2019)
Figure Global Others Revenue and Growth Rate (2017-2019)
Table Global Organoids Revenue and Revenue Share by Applications (2017-2019)
Figure Global Developmental Biology Revenue and Growth Rate (2017-2019)
Figure Global Disease Pathology of Infectious Disease Revenue and Growth Rate (2017-2019)
Figure Global Regenerative Medicine Revenue and Growth Rate (2017-2019)
Figure Global Drug Toxicity and Efficacy Testing Revenue and Growth Rate (2017-2019)
Figure Global Drug Discovery & Personalized Medicine Revenue and Growth Rate (2017-2019)
Figure Global Others Revenue and Growth Rate (2017-2019)
Table Global Organoids Revenue by Regions (2017-2019)
Figure North America Organoids Growth Rate (2017-2019)
Figure North America Organoids Revenue and Growth Rate (2017-2019)
Figure North America Organoids by Countries (2017-2019)
Figure North America Organoids Revenue (Million USD) by Countries (2017-2019)
Figure United States Organoids Growth Rate (2017-2019)
Figure United States Organoids Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Canada Organoids Growth Rate (2017-2019)
Figure Canada Organoids Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Mexico Organoids Growth Rate (2017-2019)
Figure Mexico Organoids Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Europe Organoids Growth Rate (2017-2019)
Figure Europe Organoids Revenue and Growth Rate (2017-2019)
Figure Europe Organoids by Countries (2017-2019)
Figure Europe Organoids Revenue (Million USD) by Countries (2017-2019)
Figure Germany Organoids Growth Rate (2017-2019)
Figure Germany Organoids Revenue (Millions USD) and Growth Rate (2017-2019)
Figure France Organoids Growth Rate (2017-2019)
Figure France Organoids Revenue (Millions USD) and Growth Rate (2017-2019)
Figure UK Organoids Growth Rate (2017-2019)
Figure UK Organoids Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Russia Organoids Growth Rate (2017-2019)
Figure Russia Organoids Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Italy Organoids Growth Rate (2017-2019)
Figure Italy Organoids Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Europe Organoids Growth Rate (2017-2019)
Figure Rest of Europe Organoids Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Asia-Pacific Organoids Growth Rate (2017-2019)
Figure Asia-Pacific Organoids Revenue and Growth Rate (2017-2019)
Figure Asia-Pacific Organoids by Countries (2017-2019)
Figure Asia-Pacific Organoids Revenue (Million USD) by Countries (2017-2019)
Figure China Organoids Growth Rate (2017-2019)
Figure China Organoids Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Japan Organoids Growth Rate (2017-2019)
Figure Japan Organoids Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Korea Organoids Growth Rate (2017-2019)
Figure Korea Organoids Revenue (Millions USD) and Growth Rate (2017-2019)
Figure India Organoids Growth Rate (2017-2019)
Figure India Organoids Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Southeast Asia Organoids Growth Rate (2017-2019)
Figure Southeast Asia Organoids Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Organoids Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Organoids Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South America Organoids Growth Rate (2017-2019)
Figure South America Organoids Revenue and Growth Rate (2017-2019)
Figure South America Organoids by Countries (2017-2019)
Figure South America Organoids Revenue (Million USD) by Countries (2017-2019)
Figure Brazil Organoids Growth Rate (2017-2019)
Figure Brazil Organoids Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Argentina Organoids Growth Rate (2017-2019)
Figure Argentina Organoids Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Columbia Organoids Growth Rate (2017-2019)
Figure Columbia Organoids Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of South America Organoids Growth Rate (2017-2019)
Figure Rest of South America Organoids Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Middle East and Africa Organoids Growth Rate (2017-2019)
Figure Middle East and Africa Organoids Revenue and Growth Rate (2017-2019)
Figure Middle East and Africa Organoids by Countries (2017-2019)
Figure Middle East and Africa Organoids Revenue (Million USD) by Countries (2017-2019)
Figure Saudi Arabia Organoids Growth Rate (2017-2019)
Figure Saudi Arabia Organoids Revenue (Millions USD) and Growth Rate (2017-2019)
Figure United Arab Emirates Organoids Growth Rate (2017-2019)
Figure United Arab Emirates Organoids Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Egypt Organoids Growth Rate (2017-2019)
Figure Egypt Organoids Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Nigeria Organoids Growth Rate (2017-2019)
Figure Nigeria Organoids Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South Africa Organoids Growth Rate (2017-2019)
Figure South Africa Organoids Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Turkey Organoids Growth Rate (2017-2019)
Figure Turkey Organoids Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Organoids Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Organoids Revenue (Millions USD) and Growth Rate (2017-2019)
Table STEMCELL Technologies, Inc. Organoids Financial Overview
Table Cellesce Ltd. Organoids Financial Overview
Table Hubrecht Organoid Technology Organoids Financial Overview
Table Definigen Organoids Financial Overview
Table 3Dnamics, Inc. Organoids Financial Overview
Table Organoid Therapeutics Organoids Financial Overview
Table PeproTech, Inc. Organoids Financial Overview
Table Thermo Fisher Scientific Organoids Financial Overview
Table Corning Incorporated (Life Sciences) Organoids Financial Overview
Table Merck KGgA Organoids Financial Overview
Figure Global Organoids Revenue (Millions USD) and Growth Rate (2019-2027)
Table Organoids Market Forecast by Regions (2019-2027)
Figure North America Organoids Market Forecast (2019-2027)
Figure United States Organoids Market Forecast (2019-2027)
Figure Canada Organoids Market Forecast (2019-2027)
Figure Mexico Organoids Market Forecast (2019-2027)
Figure Europe Organoids Market Forecast (2019-2027)
Figure Germany Organoids Market Forecast (2019-2027)
Figure France Organoids Market Forecast (2019-2027)
Figure UK Organoids Market Forecast (2019-2027)
Figure Russia Organoids Market Forecast (2019-2027)
Figure Italy Organoids Market Forecast (2019-2027)
Figure Rest of Europe Organoids Market Forecast (2019-2027)
Figure Asia-Pacific Organoids Market Forecast (2019-2027)
Figure China Organoids Market Forecast (2019-2027)
Figure Japan Organoids Market Forecast (2019-2027)
Figure Korea Organoids Market Forecast (2019-2027)
Figure India Organoids Market Forecast (2019-2027)
Figure Southeast Asia Organoids Market Forecast (2019-2027)
Figure Rest of Asia-Pacific Organoids Market Forecast (2019-2027)
Figure South America Organoids Market Forecast (2019-2027)
Figure Brazil Organoids Market Forecast (2019-2027)
Figure Argentina Organoids Market Forecast (2019-2027)
Figure Columbia Organoids Market Forecast (2019-2027)
Figure Rest of South America Organoids Market Forecast (2019-2027)
Figure Middle East and Africa Organoids Market Forecast (2019-2027)
Figure Saudi Arabia Organoids Market Forecast (2019-2027)
Figure United Arab Emirates Organoids Market Forecast (2019-2027)
Figure Egypt Organoids Market Forecast (2019-2027)
Figure Nigeria Organoids Market Forecast (2019-2027)
Figure South Africa Organoids Market Forecast (2019-2027)
Figure Turkey Organoids Market Forecast (2019-2027)
Figure Rest of Middle East and Africa Organoids Market Forecast (2019-2027)
Figure Global Organoids Forecast by Product Type (2019-2027)
Figure Global Organoids Market Share Forecast by Product Type (2019-2027)
Figure Global Organoids Forecast by Product Type (2019-2027)
Figure Global Organoids Forecast by Applications (2019-2027)
Figure Global Organoids Market Share Forecast by Applications (2019-2027)
Figure Global Organoids Forecast by Applications (2019-2027)

Please Note: Data related to the Companies are subject to Availability.


Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources

  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources

  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

data triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)

  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country

License Type

For Any Assistance

*
*
*
*
*